TET1 and breast carcinoma: Hsu et al. found that TET1 normally maintains expression of tissue inhibitors of metalloproteinases (TIMPS) and that down-regulation of TET1 in breast cancer facilitates migration and invasion of cancer cells and correlates with advanced tumor stage and poor survival [143].